Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Molecular Templates | MTEM | Nov 26, 2024 | 0.37 | -7.87 |
Moleculin Biotech | MBRX | Nov 26, 2024 | 2.62 | -1.13 |
Molina Healthcare | MOH | Nov 26, 2024 | 296.84 | -0.38 |
Molson Coors B | TAP | Nov 26, 2024 | 61.41 | +1.22 |
Molson Coors Beverage Company A | TAP-A | Nov 26, 2024 | 60.00 | 0.00 |
Momentus A | MNTS | Nov 26, 2024 | 0.55 | -6.40 |
Monarch Casino & Resort | MCRI | Nov 26, 2024 | 85.69 | -0.19 |
Monday.com | MNDY | Nov 26, 2024 | 293.00 | -1.05 |
Mondee | MOND | Nov 26, 2024 | 0.96 | -6.09 |
Mondelez International A | MDLZ | Nov 26, 2024 | 64.88 | -0.09 |
Moneyhero | MNY | Nov 26, 2024 | 1.14 | -1.72 |
MoneyLion A | ML | Nov 26, 2024 | 86.64 | -0.01 |
MongoDB A | MDB | Nov 26, 2024 | 335.40 | -1.75 |
Monogram Technologies | MGRM | Nov 26, 2024 | 2.07 | -0.48 |
Monolithic Power Systems | MPWR | Nov 26, 2024 | 572.08 | -4.79 |
Monopar Therapeutics | MNPR | Nov 26, 2024 | 19.45 | +0.26 |
Monro | MNRO | Nov 26, 2024 | 27.73 | -1.91 |
Monroe Capital | MRCC | Nov 26, 2024 | 8.48 | -0.12 |
Monster Beverage | MNST | Nov 26, 2024 | 54.83 | -0.27 |
Montauk Renewables | MNTK | Nov 26, 2024 | 4.30 | -4.23 |
Monte Rosa Therapeutics | GLUE | Nov 26, 2024 | 8.60 | +1.65 |
Montrose Environmental Group | MEG | Nov 26, 2024 | 18.14 | -5.77 |
Moodys | MCO | Nov 26, 2024 | 499.66 | +1.14 |
Moog A | MOG-A | Nov 26, 2024 | 223.87 | -0.07 |
Moog B | MOG-B | Nov 26, 2024 | 214.95 | 0.00 |
Moolec Science | MLEC | Nov 26, 2024 | 0.88 | -1.12 |
MoonLake Immunotherapeutics | MLTX | Nov 26, 2024 | 52.84 | -2.46 |
Morgan Stanley | MS | Nov 26, 2024 | 131.28 | -1.78 |
Morgan Stanley China A Share Fund | CAF | Nov 26, 2024 | 12.28 | -0.41 |
Morgan Stanley Direct Lending Fund | MSDL | Nov 26, 2024 | 20.74 | -0.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.